RTM looks great I bought today at 8.8 cents, chart wise there is no reason this stock won't test the 17.5 cents level again.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago